FlowIntell revolutionizes women’s reproductive health with a non-invasive at-home endometriosis screening kit, targeting those suffering from undiagnosed menstrual pain and inflammation. Given the prolonged diagnostic timeline (average of 10 years) for the 10% of women affected by endometriosis, our solution serves as a crucial pathway. Our at-home kit delivers same-day results, affordable clarity, and convenience, mitigating the pain points of endometriosis diagnosis. In contrast to traditional surgical procedures, FlowIntell’s screening kit is cost-effective, rapid, and minimally invasive.
Read more at www.flowintell.org
Nine companies will compete on the Main Stage for $10,000 in prizes.